Automation will be key to improving efficiency and mitigating risk during the complex process of cell therapy production and delivery.
Rolf Ehrhardt
Advertisement
Rolf Ehrhardt, MD, PhD is CEO of MedCision.
Articles by Rolf Ehrhardt
In this article, MedCision executive discusses cell therapies.
Advertisement
Latest Updated Articles
- The Success of Cell Therapies Will Depend on Automation
Published: July 14th 2017 | Updated:
The Success of Cell Therapies Will Depend on AutomationPublished: October 1st 2017 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
